ACADIA Pharmaceuticals Stock (NASDAQ: ACAD) stock price, news, charts, stock research, profile.
Open | $17.88 |
Close | - |
Volume / Avg. | 197.85K / 1.75M |
Day Range | 17.79 - 18.09 |
52 Wk Range | 14.55 - 33.13 |
Market Cap | $2.97B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 64 |
Short Interest | 9.77% |
Days to Cover | 6.41 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ACADIA Pharmaceuticals (NASDAQ:ACAD) through any online brokerage.
Other companies in ACADIA Pharmaceuticals’s space includes: IDEAYA Biosciences (NASDAQ:IDYA), Twist Bioscience (NASDAQ:TWST), Ultragenyx Pharmaceutical (NASDAQ:RARE), MoonLake (NASDAQ:MLTX) and SpringWorks Therapeutics (NASDAQ:SWTX).
There is no analysis for ACADIA Pharmaceuticals.
ACADIA Pharmaceuticals has a consensus price target of $28.57.
The stock price for ACADIA Pharmaceuticals (NASDAQ: ACAD) is $17.6 last updated Today at July 22, 2024 at 9:00 AM EDT.
There are no upcoming dividends for ACADIA Pharmaceuticals.
ACADIA Pharmaceuticals’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for ACADIA Pharmaceuticals.
ACADIA Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.